Purchases and Sales Made in Q2 2024 in Caribou Biosciences, Inc. (CRBU)
This table provides information about the institutional ownership of Caribou Biosciences, Inc. (CRBU) during Q2 2024. The information is specifically focused on institutions that hold shares of Caribou Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-203K- 24.67% |
$330K - $1.03M
|
621K
$938K
|
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-227K- 98.83% |
$369K - $1.15M
|
2.7K
$4.07K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-302K- 73.91% |
$489K - $1.52M
|
107K
$161K
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-417K- 88.8% |
$675K - $2.11M
|
52.6K
$79.4K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-464K- 88.14% |
$752K - $2.35M
|
62.5K
$94.4K
|
|
|
Aug 05, 2024
Q2 2024
|
Candriam S.C.A.
|
SELL
|
- |
-520K- 45.41% |
$842K - $2.63M
|
625K
$944K
|
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-951K- 51.61% |
$1.54M - $4.8M
|
892K
$1.35M
|
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.24M- 34.63% |
$2.01M - $6.27M
|
2.34M
$3.54M
|
|
|
Aug 14, 2024
Q2 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-2.4M- 37.02% |
$3.89M - $12.1M
|
4.08M
$6.17M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-4.73M- 74.55% |
$7.67M - $23.9M
|
1.62M
$2.44M
|